MCMedicalCodingSoftware
Free trial
3E0F80M

3E0F80M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduction of Antneo, Moncln Ab, into Resp Tract, Endo

How 3E0F80M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. FBody partThe specific site
  5. 8ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0F80M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0F7HZIntroduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7KZIntroduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7NZIntroduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7SDIntroduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7SFIntroduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7TZIntroduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F804Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F805Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F80MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F828Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F829Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F83ZIntroduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F86ZIntroduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F87ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F8BZIntroduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F8GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0F8HZIntroduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
ICD-10-PCSFY2026